NCT07875036Recruiting
Comparative Effects of Coherent Breathing and Regular Paced Breathing on Dyspnea and Pulmonary Function in Patients With Chronic Obstructive Pulmonary Disease
Source: ClinicalTrials.gov · Last updated 15 Oct 2026
Brief summary (registry, in English)
Chronic Obstructive Pulmonary Disease (COPD) is an inflammatory condition of airways characterized by recurrent episodes of coughing, respiratory muscle weakness, lung hyperinflation and air trapping which ultimately leads to dyspnea, impaired pulmonary function and reduced quality of life. Non- pharmacological approaches, particularly breathing retraining techniques, have gained recognition as complementary strategies for optimizing COPD management by improving overall functional status and exercise tolerance in the patients.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 46 (estimated)
- First submitted
- 7 Oct 2026
- Start date
- 11 Feb 2026
- Primary completion date
- 15 Dec 2026
- Lead sponsor
- Foundation University Islamabad
- Diseases
- COPD
- NCT number
- NCT07875036
What you commit to
- Study type: Interventional
- Planned participants: 46
- From 11 Feb 2026 to the primary completion date, 15 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Other sgnificant respiratory diseases (e.g., asthma, bronchiectasis, ILD, active tuberculosis)
Other
- Severe and very severe stage of COPD according to GOLD classification
- Patients having acute exacerbation of COPD with in the last 4 weeks
- Hemodnamically unstable patients
- Current smokers (active smoking or individuals using any tobacco product within the 6 months)
- Patients unable to follow commands/instructions
- Patients currently participating in any other structured pulmonary rehabilitation or breathing intervention program
Who the study is looking for
- Age between 40-75 years.
- Both genders (male and females).
- Diagnosed COPD mild to moderate stage according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification:
- Mild: FEV1 ≥ 80% predicted Moderate: FEV1 fall between 50-79%
- Diagnosed with COPD for at least 6 months prior to enrollment in study
- Resting SpO₂ ≥ 90% on room air
Age in the registry: 40 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Foundation University Islamabad Coordinator of this site? Confirm its status | Rawalpindi | Pakistan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.